BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19487548)

  • 21. Comparative effects of soy phytoestrogens and 17β-estradiol on DNA methylation of a panel of 24 genes in prostate cancer cell lines.
    Adjakly M; Ngollo M; Lebert A; Dagdemir A; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D
    Nutr Cancer; 2014; 66(3):474-82. PubMed ID: 24641702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Phytoestrogen Genistein Affects Breast Cancer Cells Treatment Depending on the ERα/ERβ Ratio.
    Pons DG; Nadal-Serrano M; Torrens-Mas M; Oliver J; Roca P
    J Cell Biochem; 2016 Jan; 117(1):218-29. PubMed ID: 26100284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
    Gougelet A; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of phytoestrogens on growth-related and lipogenic genes in rainbow trout (Oncorhynchus mykiss).
    Cleveland BM; Manor ML
    Comp Biochem Physiol C Toxicol Pharmacol; 2015 Apr; 170():28-37. PubMed ID: 25668741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERalpha/ERbeta ratio.
    Sotoca AM; Ratman D; van der Saag P; Ström A; Gustafsson JA; Vervoort J; Rietjens IM; Murk AJ
    J Steroid Biochem Mol Biol; 2008 Dec; 112(4-5):171-8. PubMed ID: 18955141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of estrogen receptor-beta isoforms by phytoestrogens in breast cancer cells.
    Cappelletti V; Miodini P; Di Fronzo G; Daidone MG
    Int J Oncol; 2006 May; 28(5):1185-91. PubMed ID: 16596234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genistein affects HER2 protein concentration, activation, and promoter regulation in BT-474 human breast cancer cells.
    Sakla MS; Shenouda NS; Ansell PJ; Macdonald RS; Lubahn DB
    Endocrine; 2007 Aug; 32(1):69-78. PubMed ID: 17992604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression profiling in Ishikawa cells: a fingerprint for estrogen active compounds.
    Boehme K; Simon S; Mueller SO
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):85-96. PubMed ID: 19371625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30.
    Vivacqua A; Bonofiglio D; Albanito L; Madeo A; Rago V; Carpino A; Musti AM; Picard D; Andò S; Maggiolini M
    Mol Pharmacol; 2006 Oct; 70(4):1414-23. PubMed ID: 16835357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of 17β-estradiol and flavonoids on the regulation of expression of newly identified oestrogen responsive genes in a rat raphe nuclei-derived cell line.
    Amer DA; Jähne M; Weigt C; Kretzschmar G; Vollmer G
    J Cell Physiol; 2012 Oct; 227(10):3434-45. PubMed ID: 22213181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of microRNA associated with ovarian cancer cells by genistein.
    Parker LP; Taylor DD; Kesterson J; Metzinger DS; Gercel-Taylor C
    Eur J Gynaecol Oncol; 2009; 30(6):616-21. PubMed ID: 20099489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen.
    O'Donnell AJ; Macleod KG; Burns DJ; Smyth JF; Langdon SP
    Endocr Relat Cancer; 2005 Dec; 12(4):851-66. PubMed ID: 16322326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation.
    Power KA; Thompson LU
    Breast Cancer Res Treat; 2003 Oct; 81(3):209-21. PubMed ID: 14620916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genistein in the presence of 17beta-estradiol inhibits proliferation of ERbeta breast cancer cells.
    Rajah TT; Du N; Drews N; Cohn R
    Pharmacology; 2009; 84(2):68-73. PubMed ID: 19556829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of lower concentrations of phytoestrogens on the effects of estradiol in breast cancer cells.
    Chen FP; Chien MH; Chern IY
    Climacteric; 2015; 18(4):574-81. PubMed ID: 25581323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta.
    Monroe DG; Getz BJ; Johnsen SA; Riggs BL; Khosla S; Spelsberg TC
    J Cell Biochem; 2003 Oct; 90(2):315-26. PubMed ID: 14505348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term treatment of ovariectomized mice with estradiol or phytoestrogens as a new model to study the role of estrogenic substances in the heart.
    Nguyen BT; Kararigas G; Wuttke W; Jarry H
    Planta Med; 2012 Jan; 78(1):6-11. PubMed ID: 21928168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose- and Time-Dependent Transcriptional Response of Ishikawa Cells Exposed to Genistein.
    Naciff JM; Khambatta ZS; Carr GJ; Tiesman JP; Singleton DW; Khan SA; Daston GP
    Toxicol Sci; 2016 May; 151(1):71-87. PubMed ID: 26865667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estradiol Receptors Regulate Differential Connexin 43 Expression in F98 and C6 Glioma Cell Lines.
    Moinfar Z; Dambach H; Schoenebeck B; Förster E; Prochnow N; Faustmann PM
    PLoS One; 2016; 11(2):e0150007. PubMed ID: 26919293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells.
    Zhou S; Turgeman G; Harris SE; Leitman DC; Komm BS; Bodine PV; Gazit D
    Mol Endocrinol; 2003 Jan; 17(1):56-66. PubMed ID: 12511606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.